G56W1 in Women With Postmenopausal Osteoporosis

NCT03720886 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

BIOLOGICAL: rhPTH（1-34） 28.2μg
BIOLOGICAL: rhPTH（1-34） 56.5μg
BIOLOGICAL: teriparatide acetate(Teribone™)

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.